EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Immediate and delayed hypersensitivity to biologicals in children—A practical approach: An EAACI task force report

Francesca Mori iD, Marina Atanaskovic-Markovic iD, Annick Barbaud iD, Sevim Bavbek iD, Jean-Christoph Caubet iD, Leticia de Las Vecillas iD, Mattia Giovannini iD, Ekaterina Khaleva iD, Marina Labella iD, Luis Moral iD, Carmen Riggioni iD, Vito Sabato und 2 weitere

Pediatric Allergy and Immunology · 2026-04 · 37 (4)

DOI: 10.1111/pai.70277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 05.04.2026. Verfasst von Francesca Mori und 13 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy. Hauptthemen laut MEDLINE: Hypersensitivity, Immediate, Hypersensitivity, Delayed, Drug Hypersensitivity, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Academy of Allergy and Clinical Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the era of precision medicine, biologicals demonstrate how therapies can be personalized and directed against new targets. This type of therapy includes different molecules such as growth factors, immune modulators, vaccines, and monoclonal antibodies (mAbs). In recent years, biologicals have been increasingly developed and authorized, although their use in children is limited compared to that in adults, due to the complexity of the pharmacokinetics and pharmacodynamics of the involved proteins, as well as other factors, such as regulations governing clinical trials. Regardless, biologicals are used with efficacy in children to treat various diseases, including oncological, hematological, atopic, and rheumatological diseases. In parallel with the increased use of biologicals, there has been an increase in the unwanted effects of these agents. This paper aims to provide physicians with a practical approach to differentiate between the types of reactions to biologicals in children, especially mAbs, based on the frequency of use, for a comprehensive allergy workup. Starting from a clinical case (i.e., phenotype), specific biomarkers of the involved molecular mechanism (i.e., endotype) are described, providing the reader with currently known instruments to guide the diagnosis. Finally, practical limitations, preventive measures, and unmet needs were discussed by a panel of experts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypersensitivity, ImmediateHypersensitivity, DelayedDrug HypersensitivityBiological ProductsHumansChildAntibodies, MonoclonalBiomarkers

Stichwörter der Autor:innen

biologicalschildrendelayedhypersensitivityimmediate

Substanzen

Biological ProductsAntibodies, MonoclonalBiomarkers

Autor:innen und Institutionen

  • Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • University Children's Hospital of Belgrade, Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Sante Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Paris, France.
  • Département de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.
  • Department of Chest Disease, Division of Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.

ORCID-Profile: Francesca Mori, Marina Atanaskovic-Markovic, Annick Barbaud, Sevim Bavbek, Jean-Christoph Caubet, Leticia de Las Vecillas, Mattia Giovannini, Ekaterina Khaleva, Marina Labella, Luis Moral, Carmen Riggioni, Sophia Tsabouri, Stefania Arasi

Förderung

  • European Academy of Allergy and Clinical Immunology

Zitieren

APA

Mori, F., Atanaskovic-Markovic, M., Barbaud, A., Bavbek, S., Caubet, J. C., de Las Vecillas, L., Giovannini, M., Khaleva, E., Labella, M., Moral, L., Riggioni, C., Sabato, V., Tsabouri, S., & Arasi, S. (2026). Immediate and delayed hypersensitivity to biologicals in children—A practical approach: An EAACI task force report. Pediatric Allergy and Immunology, 37(4). https://doi.org/10.1111/pai.70277

Vancouver

Mori F, Atanaskovic-Markovic M, Barbaud A, Bavbek S, Caubet JC, de Las Vecillas L, et al. Immediate and delayed hypersensitivity to biologicals in children—A practical approach: An EAACI task force report. Pediatric Allergy and Immunology. 2026;37(4). doi:10.1111/pai.70277

BibTeX
@article{Mori2026,
  author = {Mori, Francesca and Atanaskovic-Markovic, Marina and Barbaud, Annick and Bavbek, Sevim and Caubet, Jean-Christoph and de Las Vecillas, Leticia and Giovannini, Mattia and Khaleva, Ekaterina and Labella, Marina and Moral, Luis and Riggioni, Carmen and Sabato, Vito and Tsabouri, Sophia and Arasi, Stefania},
  title = {Immediate and delayed hypersensitivity to biologicals in children—A practical approach: An EAACI task force report},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {4},
  doi = {10.1111/pai.70277}
}
Kostenlos starten →